Privium Fund Management B.V. — 13F Holdings & Portfolio
CIK 1795097 · latest 13F-HR filed 2026-05-05
Privium Fund Management B.V. manages $480.3M in 13F-reported U.S. long-equity assets across 60 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are TSLA (17.18%), SHOP (10.05%), SPOT (6.76%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 7 new positions, exited 4, added to 15, and trimmed 30.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$480.3M
Long-equity book
60
Distinct positions
2026-03-31
Filed 2026-05-05
+7 / −4 / ↑15 / ↓30
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- IONIS PHARMACEUTICALS INC$2.7M +14.3%
- AST SPACEMOBILE INC$1.5M +14.1%
- VERTEX PHARMACEUTICALS INC$829.3K +19.6%
- PFIZER INC$539.3K +57.4%
- ROCKET PHARMACEUTICALS INC$269.7K +45.2%
Top Trims
- TESLA INC-$20.2M -19.7%
- SHOPIFY INC-$17.7M -26.8%
- SPOTIFY TECHNOLOGY S A-$7.0M -17.7%
- PALANTIR TECHNOLOGIES INC-$6.3M -17.7%
- SEA LTD-$6.2M -35.1%
New Positions
- ESPERION THERAPEUTICS INC NE$9.0M
- BIOMARIN PHARMACEUTICAL INC$5.2M
- DENALI THERAPEUTICS INC$4.9M
- ALNYLAM PHARMACEUTICALS INC$4.0M
- MOLINA HEALTHCARE INC$1.1M
Exited Positions
- MERCK & CO INC$3.9M
- VIZSLA SILVER CORP$1.1M
- VALARIS LTD$318.3K
- NOMAD FOODS LTD$102.6K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | TESLA INC | TSLA | 88160R101 | $82.5M | 17.18% | 222,000 | SH |
| 2 | SHOPIFY INC | SHOP | 82509L107 | $48.3M | 10.05% | 407,000 | SH |
| 3 | SPOTIFY TECHNOLOGY S A | SPOT | L8681T102 | $32.5M | 6.76% | 67,000 | SH |
| 4 | PALANTIR TECHNOLOGIES INC | PLTR | 69608A108 | $29.3M | 6.09% | 200,000 | SH |
| 5 | AMAZON COM INC | AMZN | 023135106 | $26.0M | 5.42% | 125,000 | SH |
| 6 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $23.0M | 4.79% | 366,936 | SH |
| 7 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $21.8M | 4.53% | 290,024 | SH |
| 8 | LEMONADE INC | LMND | 52567D107 | $16.0M | 3.33% | 255,259 | SH |
| 9 | NVIDIA CORPORATION | NVDA | 67066G104 | $14.1M | 2.94% | 81,000 | SH |
| 10 | COINBASE GLOBAL INC | COIN | 19260Q107 | $13.8M | 2.87% | 79,000 | SH |
| 11 | ADVANCED MICRO DEVICES INC | AMD | 007903107 | $12.6M | 2.63% | 62,000 | SH |
| 12 | AST SPACEMOBILE INC | ASTS | 00217D100 | $12.0M | 2.50% | 145,000 | SH |
| 13 | SEA LTD | SE | 81141R100 | $11.4M | 2.38% | 138,000 | SH |
| 14 | IREN LIMITED | IREN | Q4982L109 | $11.0M | 2.28% | 320,150 | SH |
| 15 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $9.9M | 2.07% | 58,729 | SH |
| 16 | ESPERION THERAPEUTICS INC NE | ESPR | 29664W105 | $9.0M | 1.88% | 3,299,441 | SH |
| 17 | PROQR THRAPEUTICS N V | PRQR | N71542109 | $8.9M | 1.84% | 5,467,149 | SH |
| 18 | BIOGEN INC | BIIB | 09062X103 | $8.0M | 1.67% | 43,800 | SH |
| 19 | UNIQURE NV | QURE | N90064101 | $8.0M | 1.66% | 486,520 | SH |
| 20 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 90400D108 | $7.6M | 1.59% | 364,802 | SH |
| 21 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 03969K108 | $7.6M | 1.57% | 320,972 | SH |
| 22 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $5.2M | 1.09% | 92,305 | SH |
| 23 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $5.1M | 1.06% | 11,355 | SH |
| 24 | DENALI THERAPEUTICS INC | DNLI | 24823R105 | $4.9M | 1.02% | 254,857 | SH |
| 25 | UROGEN PHARMA LTD | URGN | M96088105 | $4.3M | 0.89% | 238,122 | SH |
| 26 | ALNYLAM PHARMACEUTICALS INC | ALNY | 02043Q107 | $4.0M | 0.84% | 12,222 | SH |
| 27 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $3.4M | 0.71% | 173,516 | SH |
| 28 | KRYSTAL BIOTECH INC | KRYS | 501147102 | $2.9M | 0.60% | 11,170 | SH |
| 29 | AMBEV SA | ABEV | 02319V103 | $2.8M | 0.58% | 948,558 | SH |
| 30 | ZAI LAB LTD | ZLAB | 98887Q104 | $2.5M | 0.52% | 132,189 | SH |
| 31 | BIONTECH SE | BNTX | 09075V102 | $2.4M | 0.50% | 27,000 | SH |
| 32 | ENGENE HOLDINGS INC | ENGNW | 29286M105 | $2.4M | 0.50% | 352,087 | SH |
| 33 | CRISPR THERAPEUTICS AG | CRSP | H17182108 | $2.0M | 0.42% | 42,874 | SH |
| 34 | MEIRAGTX HLDGS PLC | MGTX | G59665102 | $1.8M | 0.38% | 212,112 | SH |
| 35 | WAVE LIFE SCIENCES LTD | WVE | Y95308105 | $1.7M | 0.36% | 241,010 | SH |
| 36 | STOKE THERAPEUTICS INC | STOK | 86150R107 | $1.6M | 0.34% | 50,000 | SH |
| 37 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 35104E100 | $1.6M | 0.33% | 170,256 | SH |
| 38 | BEAM THERAPEUTICS INC | BEAM | 07373V105 | $1.5M | 0.32% | 63,982 | SH |
| 39 | MODERNA INC | MRNA | 60770K107 | $1.5M | 0.32% | 29,994 | SH |
| 40 | PFIZER INC | PFE | 717081103 | $1.5M | 0.31% | 52,679 | SH |
| 41 | LEXEO THERAPEUTICS INC | LXEO | 52886X107 | $1.2M | 0.24% | 205,000 | SH |
| 42 | CARTESIAN THERAPEUTICS INC | RNAC | 816212302 | $1.1M | 0.23% | 179,114 | SH |
| 43 | MOLINA HEALTHCARE INC | MOH | 60855R100 | $1.1M | 0.23% | 8,140 | SH |
| 44 | SAREPTA THERAPEUTICS INC | SRPT | 803607100 | $1.0M | 0.21% | 46,000 | SH |
| 45 | SLB LIMITED | SLB | 806857108 | $948.2K | 0.20% | 18,451 | SH |
| 46 | ROCKET PHARMACEUTICALS INC | RCKT | 77313F106 | $866.9K | 0.18% | 242,146 | SH |
| 47 | HIMS & HERS HEALTH INC | HIMS | 433000106 | $830.4K | 0.17% | 40,000 | SH |
| 48 | TAYSHA GENE THERAPIES INC | TSHA | 877619106 | $813.1K | 0.17% | 181,900 | SH |
| 49 | NOV INC | NOV | 62955J103 | $790.5K | 0.16% | 42,026 | SH |
| 50 | TRANSOCEAN LTD | RIG | H8817H100 | $706.8K | 0.15% | 106,604 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | $480.3M | 60 | 0001754960-26-000356 |
| 2025-12-31 | 2026-02-03 | $543.1M | 57 | 0001754960-26-000150 |